HIF1A and diabetes mellitus: A recent study suggested that treating MSCs with estradiol promotes the migration of cells in cultured MSCs and a cell therapy model of diabetes via adjustment of critical mediators of cell trafficking like hypoxia-inducible factor-1a (HIF-1a) (9).